Loading market dashboard
KalVista Pharmaceuticals, Inc.
KALVHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
KalVista Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $589.46M | $575.98M - $602.94M | $353.68M | $3.606 | 3 |
| Dec 2029 | $512.97M | $501.24M - $524.70M | $307.78M | $3.118 | 5 |
| Dec 2028 | $425.40M | $415.67M - $435.13M | $255.24M | $2.024 | 2 |
| Dec 2027 | $310.95M | $303.84M - $318.06M | $186.57M | $0.64 | 6 |
| Dec 2026 | $199.04M | $190.14M - $207.94M | $119.43M | -$1.211 | 3 |
| Dec 2025 | $48.22M | $34.16M - $55.76M | $28.93M | -$2.801 | 5 |
| Dec 2024 | $4.46M | $4.36M - $4.57M | $2.68M | -$3.566 | 4 |
| Apr 2024 | $4.46M | $4.37M - $4.55M | $0.00 | -$3.031 | 6 |
| Apr 2020 | $10.54M | $9.58M - $11.15M | $0.00 | -$1.938 | 2 |
| Apr 2019 | $17.23M | $15.66M - $18.24M | $0.00 | -$1.226 | 1 |
| Apr 2018 | $7.22M | $6.56M - $7.64M | $0.00 | -$1.835 | 2 |
| Apr 2016 | $23.7K | $21.5K - $25.1K | $0.00 | -$16.03 | 1 |